The number of people with susceptibility test result for rifampicin in Slovenia
Slovenia: The number of people with susceptibility test result for rifampicin was 58 in 2021. ▼ Falling
Latest (2021)
58
Change on year
up 1.8%
World rank
119th
of 155 countries
All-time high
85
in 2017
All-time low
57
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Slovenia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Slovenia recorded 58 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 1.8% on the previous year and down 31.8% over five years.
Slovenia ranks 119th of 155 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Slovenia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 85 | — |
| 2018 | 70 | -17.6% |
| 2019 | 78 | +11.4% |
| 2020 | 57 | -26.9% |
| 2021 | 58 | +1.8% |
Slovenia compared with similar countries
- Slovenia's 58 is below the median for high income countries, which is 142, 41% of the median. (61 countries reporting)
- Slovenia's 58 is below the median for Europe & Central Asia, which is 229.5, 25% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 77.67 | 70 | 85 | 3 |
| 2020s | 57.5 | 57 | 58 | 2 |
Countries ranked near Slovenia
More health data for Slovenia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8177 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,176 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.03 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Slovenia?
- The number of people with susceptibility test result for rifampicin in Slovenia was 58 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Slovenia?
- The highest recorded value was 85 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Slovenia?
- The lowest recorded value was 57 in 2020.
- How does Slovenia rank for the number of people with susceptibility test result for rifampicin?
- Slovenia ranks 119th out of 155 countries with data for 2021.
- Where does this Slovenia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).